Skip to content
← Back to this collection

PUBLICATIONS · 8622028

Patients with limited-stage small-cell lung cancer treated with concurrent twice-daily chest radiotherapy and etoposide/cisplatin followed by cyclophosphamide, doxorubicin, and vincristine.

Open original source → · Download preserved record

Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.

Journal
J Clin Oncol
Publication date
1996 Mar
First author
Johnson BE

Publication notices

absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships

    Authors and identifiers

    1. name
      Johnson BE
      type
      Author
    2. name
      Bridges JD
      type
      Author
    3. name
      Sobczeck M
      type
      Author
    4. name
      Gray J
      type
      Author
    5. name
      Linnoila RI
      type
      Author
    6. name
      Gazdar AF
      type
      Author
    7. name
      Hankins L
      type
      Author
    8. name
      Steinberg SM
      type
      Author
    9. name
      Edison M
      type
      Author
    10. name
      Frame JN
      type
      Author
    11. name
      Pass H
      type
      Author
    12. name
      Nesbitt J
      type
      Author
    Complete bibliographic record and source provenance
    authors
    1. name
      Johnson BE
      type
      Author
    2. name
      Bridges JD
      type
      Author
    3. name
      Sobczeck M
      type
      Author
    4. name
      Gray J
      type
      Author
    5. name
      Linnoila RI
      type
      Author
    6. name
      Gazdar AF
      type
      Author
    7. name
      Hankins L
      type
      Author
    8. name
      Steinberg SM
      type
      Author
    9. name
      Edison M
      type
      Author
    10. name
      Frame JN
      type
      Author
    11. name
      Pass H
      type
      Author
    12. name
      Nesbitt J
      type
      Author
    bibliography ids
    1. nci-bib-e58719a2699b9f22ed31f0bd
    book metadata
    content sha256
    84d20ebee553b5b34e6013fa99eea0b236a771e4a9414c905f27c41609bdd7e8
    document type
    citation
    dois
    1. 10.1200/JCO.1996.14.3.806
    electronic publication date
    display
    Source null
    precision
    missing
    year
    Source null
    evidence scope
    bibliographic_metadata_only
    id
    pubmed:8622028
    immutable id
    pubmed:8622028@84d20ebee553b5b34e6013fa99eea0b236a771e4a9414c905f27c41609bdd7e8
    journal
    abbreviation
    J Clin Oncol
    issn electronic
    Source null
    issn print
    0732-183X
    issue
    3
    name
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology
    nlm unique id
    8309333
    pages
    806-13
    volume
    14
    languages
    1. eng
    notices
    absence is not clearance
    true
    has correction metadata
    false
    has expression of concern metadata
    false
    has retraction in link
    false
    pubmed marks article retracted
    false
    pubmed marks retraction notice
    false
    relationships
      outcomes validated
      false
      pmid
      8622028
      provenance
      batch id
      6de860041cedd40f623b
      provider
      NCBI PubMed ESummary
      record sha256
      879db065542057b3cf16c0b1f8f6f3f232e1df9939cdec7116948741290e1bc7
      response sha256
      f46103bbddb69bd5f2ea5fd2e8d9cab75a19eeb01ce2a0d1f98b4d456a872039
      retrieved at
      2026-09-09T23:45:23.163950+00:00
      publication date
      display
      1996 Mar
      precision
      month
      year
      1996
      publication types
      1. Clinical Trial
      2. Clinical Trial, Phase II
      3. Journal Article
      record status
      PubMed - indexed for MEDLINE
      schema version
      1.0
      source url
      https://pubmed.ncbi.nlm.nih.gov/8622028/
      title
      Patients with limited-stage small-cell lung cancer treated with concurrent twice-daily chest radiotherapy and etoposide/cisplatin followed by cyclophosphamide, doxorubicin, and vincristine.

      Preserved source evidence · Not medical advice